Skip to main content
Erschienen in: Virchows Archiv 4/2010

01.10.2010 | Original Article

Differences in the T-bet and GATA-3 expression patterns between lymphocytic colitis and coeliac disease

verfasst von: Korinna Jöhrens, Maria Grünbaum, Ioannis Anagnostopoulos

Erschienen in: Virchows Archiv | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Lymphocytic colitis (LC) is a disease of unknown aetiology. Among other pathogenetic possibilities, an abnormal reaction to a luminal antigen has been discussed. To clarify this fact, we characterized the inflammatory infiltrate in LC and compared it with the Th1 response-related coeliac disease (CD). Biopsies from 10 LC and 10 CD patients were analyzed by immunohistochemistry for detection of T-bet, the master regulator of Th1 response and its antagonist GATA-3 in T cells employing double labellings. In LC, 10–20% of intraepithelial lymphocytes (IEL) expressed GATA-3 and the remaining T-bet, whereas in CD, all IEL were T-bet-positive. The T cells in the lamina propria of LC (65–70% CD4+; 30–35% CD8+) showed a mixed expression pattern of T-bet and GATA-3. The majority of the CD4+ T cells were GATA-3+, while T-bet and GATA-3 were expressed at a similar frequency by the CD8+ T cells. Most of the T cells in the lamina propria of CD specimens were CD4+, showing a predominant T-bet expression. Also, most of the CD8+ lamina propria T cells in CD were T-bet+. We conclude that in contrast to CD, which exhibits immunophenotypical features of a Th1-response, LC shows features of a mixed Th1/Th2 immune response.
Literatur
1.
Zurück zum Zitat Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM (1989) Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 20:18–28CrossRefPubMed Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM (1989) Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 20:18–28CrossRefPubMed
2.
Zurück zum Zitat Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG, Fordtran JS (1980) Chronic diarrhea of unknown origin. Gastroenterology 78:264–271PubMed Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG, Fordtran JS (1980) Chronic diarrhea of unknown origin. Gastroenterology 78:264–271PubMed
3.
Zurück zum Zitat Schiller LR (1999) Microscopic colitis syndrome: lymphocytic colitis and collagenous colitis. Semin Gastrointest Dis 10:145–155PubMed Schiller LR (1999) Microscopic colitis syndrome: lymphocytic colitis and collagenous colitis. Semin Gastrointest Dis 10:145–155PubMed
4.
Zurück zum Zitat Giardiello FM, Lazenby AJ, Bayless TM et al (1989) Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci 34:1730–1738CrossRefPubMed Giardiello FM, Lazenby AJ, Bayless TM et al (1989) Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci 34:1730–1738CrossRefPubMed
5.
Zurück zum Zitat Levison DA, Lazenby AJ, Yardley JH (1993) Microscopic colitis cases revisited. Gastroenterology 105:1594–1596PubMed Levison DA, Lazenby AJ, Yardley JH (1993) Microscopic colitis cases revisited. Gastroenterology 105:1594–1596PubMed
6.
Zurück zum Zitat Agnarsdottir M, Gunnlaugsson O, Orvar KB et al (2002) Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 47:1122–1128CrossRefPubMed Agnarsdottir M, Gunnlaugsson O, Orvar KB et al (2002) Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 47:1122–1128CrossRefPubMed
7.
Zurück zum Zitat LaSala PR, Chodosh AB, Vecchio JA, Schned LM, Blaszyk H (2005) Seasonal pattern of onset in lymphocytic colitis. J Clin Gastroenterol 39:891–893CrossRefPubMed LaSala PR, Chodosh AB, Vecchio JA, Schned LM, Blaszyk H (2005) Seasonal pattern of onset in lymphocytic colitis. J Clin Gastroenterol 39:891–893CrossRefPubMed
8.
Zurück zum Zitat Bohr J, Tysk C, Yang P, Danielsson D, Jarnerot G (1996) Autoantibodies and immunoglobulins in collagenous colitis. Gut 39:73–76CrossRefPubMed Bohr J, Tysk C, Yang P, Danielsson D, Jarnerot G (1996) Autoantibodies and immunoglobulins in collagenous colitis. Gut 39:73–76CrossRefPubMed
9.
Zurück zum Zitat Fine KD, Do K, Schulte K et al (2000) High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 95:1974–1982CrossRefPubMed Fine KD, Do K, Schulte K et al (2000) High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 95:1974–1982CrossRefPubMed
10.
Zurück zum Zitat McCashland TM, Donovan JP, Strobach RS, Linder J, Quigley EM (1992) Collagenous enterocolitis: a manifestation of gluten-sensitive enteropathy. J Clin Gastroenterol 15:45–51CrossRefPubMed McCashland TM, Donovan JP, Strobach RS, Linder J, Quigley EM (1992) Collagenous enterocolitis: a manifestation of gluten-sensitive enteropathy. J Clin Gastroenterol 15:45–51CrossRefPubMed
11.
Zurück zum Zitat Neurath MF, Weigmann B, Finotto S et al (2002) The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195:1129–1143CrossRefPubMed Neurath MF, Weigmann B, Finotto S et al (2002) The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 195:1129–1143CrossRefPubMed
12.
Zurück zum Zitat Weigmann B, Neurath MF (2002) T-bet and mucosal Th1 responses in the gastrointestinal tract. Gut 51:301–303CrossRefPubMed Weigmann B, Neurath MF (2002) T-bet and mucosal Th1 responses in the gastrointestinal tract. Gut 51:301–303CrossRefPubMed
13.
Zurück zum Zitat Johrens K, Anagnostopoulos I, Stein H (2005) T-bet expression patterns in coeliac disease, cryptic and overt enteropathy-type T-cell lymphoma. Histopathology 47:368–374CrossRefPubMed Johrens K, Anagnostopoulos I, Stein H (2005) T-bet expression patterns in coeliac disease, cryptic and overt enteropathy-type T-cell lymphoma. Histopathology 47:368–374CrossRefPubMed
14.
Zurück zum Zitat Hartenstein B, Teurich S, Hess J, Schenkel J, Schorpp-Kistner M, Angel P (2002) Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J 21:6321–6329CrossRefPubMed Hartenstein B, Teurich S, Hess J, Schenkel J, Schorpp-Kistner M, Angel P (2002) Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB. EMBO J 21:6321–6329CrossRefPubMed
15.
Zurück zum Zitat Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH (2005) T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307:430–433CrossRefPubMed Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH (2005) T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307:430–433CrossRefPubMed
16.
Zurück zum Zitat Mills LR, Schuman BM, Thompson WO (1993) Lymphocytic colitis. A definable clinical and histological diagnosis. Dig Dis Sci 38:1147–1151CrossRefPubMed Mills LR, Schuman BM, Thompson WO (1993) Lymphocytic colitis. A definable clinical and histological diagnosis. Dig Dis Sci 38:1147–1151CrossRefPubMed
17.
Zurück zum Zitat Zins BJ, Sandborn WJ, Tremaine WJ (1995) Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol 90:1394–1400PubMed Zins BJ, Sandborn WJ, Tremaine WJ (1995) Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol 90:1394–1400PubMed
18.
Zurück zum Zitat Matteoni CA, Goldblum JR, Wang N, Brzezinski A, Achkar E, Soffer EE (2001) Celiac disease is highly prevalent in lymphocytic colitis. J Clin Gastroenterol 32:225–227CrossRefPubMed Matteoni CA, Goldblum JR, Wang N, Brzezinski A, Achkar E, Soffer EE (2001) Celiac disease is highly prevalent in lymphocytic colitis. J Clin Gastroenterol 32:225–227CrossRefPubMed
20.
Zurück zum Zitat Yin Z, Chen C, Szabo SJ, Glimcher LH, Ray A, Craft J (2002) T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells. J Immunol 168:1566–1571PubMed Yin Z, Chen C, Szabo SJ, Glimcher LH, Ray A, Craft J (2002) T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells. J Immunol 168:1566–1571PubMed
21.
Zurück zum Zitat Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH (2003) Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci USA 100:15818–15823CrossRefPubMed Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH (2003) Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci USA 100:15818–15823CrossRefPubMed
22.
Zurück zum Zitat Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH (2002) Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338–342CrossRefPubMed Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH (2002) Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338–342CrossRefPubMed
23.
24.
Zurück zum Zitat Wang J, Young IG (2007) Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes. Allergy 62:1131–1138CrossRefPubMed Wang J, Young IG (2007) Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes. Allergy 62:1131–1138CrossRefPubMed
25.
Zurück zum Zitat Chakir H, Wang H, Lefebvre DE, Webb J, Scott FW (2003) T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods 278:157–169CrossRefPubMed Chakir H, Wang H, Lefebvre DE, Webb J, Scott FW (2003) T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods 278:157–169CrossRefPubMed
26.
Zurück zum Zitat Pai SY, Truitt ML, Ting CN, Leiden JM, Glimcher LH, Ho IC (2003) Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19:863–875CrossRefPubMed Pai SY, Truitt ML, Ting CN, Leiden JM, Glimcher LH, Ho IC (2003) Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19:863–875CrossRefPubMed
27.
Zurück zum Zitat Lametschwandtner G, Biedermann T, Schwarzler C et al (2004) Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities. J Allergy Clin Immunol 113(5):987–994CrossRefPubMed Lametschwandtner G, Biedermann T, Schwarzler C et al (2004) Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities. J Allergy Clin Immunol 113(5):987–994CrossRefPubMed
Metadaten
Titel
Differences in the T-bet and GATA-3 expression patterns between lymphocytic colitis and coeliac disease
verfasst von
Korinna Jöhrens
Maria Grünbaum
Ioannis Anagnostopoulos
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 4/2010
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-010-0961-1

Weitere Artikel der Ausgabe 4/2010

Virchows Archiv 4/2010 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …